If you are interested in the recent revolution in breast cancer treatment and personalized medicine we encourage you to listen to a recent interview with Dr. John Link.
Dr. Link shares his perspective with the Symphony Sisterhood in a 14:52 podcast interview on the “Breast Cancer Dialogues.”
ORANGE, Calif., November 13, 2012 — Breastlink Medical Group (Breastlink), a network of breast health centers offering full-service breast cancer treatment from initial screenings to completion of treatment, announced it has completed its first intraoperative radiation therapy (IORT) procedure using the Xoft Axxent® eBx System. The surgical procedure was lead by our lead surgeon at Breastlink’s Temecula Valley center.
The Xoft system for IORT delivers a single, prescribed, targeted dose of radiation during surgery directly to the tumor cavity. The U.S. Food & Drug Administration (FDA) approved the Axxent system for the treatment of breast cancer in January 2012. This breast IORT procedure was performed in conjunction with the Breastlink Research […]
Intraoperative Radiation Therapy (IORT) utilizing the Xoft System Provides Single, Targeted Dose of Radiation Therapy During Lumpectomy
NASHUA, NH and ORANGE, CA (May 4, 2012) – iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, and Breastlink Medical Group in Southern California, today announced an agreement that will make the Xoft® Axxent® Electronic Brachytherapy System® available to breast cancer patients treated at Breastlink. The Xoft system for Intraoperative Radiation Therapy (IORT) delivers a single, prescribed, targeted dose of radiation during surgery directly to the tumor cavity – minimizing radiation to healthy tissue and organs. The announcement was made during […]
